School of Medical Informatics, China Medical University, Shenyang, Liaoning, China (L.W., M.Y., J.S.); Department of Radiology, Shenjing Hospital of China Medical University, Shenyang, Liaoning, China (Z.L.); Department of Radiology, China Medical University, Shenyang, Liaoning, China (J.X., Y.C., X.Z., Z.Y.); Department of Electric and Computer Engineering, University of Texas-El Paso, El Paso, Tex (W.Q.); CAS Key Laboratory of Molecular Imaging, Institute of Automation, Chinese Academy of Sciences, Beijing, China (J.T.); and Department of Radiology, Stanford University School of Medicine, 1201 Welch Rd Lucas Center PS055, Palo Alto, CA 94305 (K.Y., J.S.).
Radiol Imaging Cancer. 2020 Sep 11;2(5):e190079. doi: 10.1148/rycan.2020190079. eCollection 2020 Sep.
To summarize the data of previously reported medical imaging features on human malignancies to provide a scientific basis for more credible imaging feature selection for future studies.
A search was performed in PubMed from database inception through March 23, 2018, for studies clearly stating the decoding of medical imaging features for malignancy-related objectives and/or hypotheses. The Newcastle-Ottawa scale was used for quality assessment of the included studies. Unsupervised hierarchical clustering was performed on the manually extracted features from each included study to identify the application rules of medical imaging features across human malignancies. CT images of 1000 retrospective patients with non-small cell lung cancer were used to reveal a pattern for the value distribution of complex texture features.
A total of 5026 imaging features of malignancies affecting 20 parts of the human body from 930 original articles were collated and assessed in this study. A meta-feature construct was proposed to facilitate the investigation of details of any high-dimensional complex imaging features of malignancy. A correlation atlas was constructed to clarify the general rules of applying medical imaging features to the analysis of human malignancy. Assessment of this data revealed a pattern of value distributions of the most commonly reported texture features across human malignancies. Furthermore, the significant expression of the gene mutational signature 1B across human cancer was highly consistent with the presence of the run length imaging feature across different human malignancy types.
The results of this study may facilitate more credible imaging feature selection in all oncology tasks across a wide spectrum of human malignancies and help to reduce bias and redundancies in future medical imaging studies. Computer Aided Diagnosis (CAD), Computer Applications-General (Informatics), Evidence Based Medicine, Informatics, Research Design, Statistics, Technology AssessmentPublished under a CC BY 4.0 license.
总结以往关于人类恶性肿瘤的医学影像学特征数据,为未来研究更可信的影像学特征选择提供科学依据。
从数据库建立到 2018 年 3 月 23 日,在 PubMed 上进行了检索,以查找明确说明为恶性肿瘤相关目标和/或假设解码医学成像特征的研究。使用纽卡斯尔-渥太华量表对纳入研究进行质量评估。对每个纳入研究中手动提取的特征进行无监督层次聚类,以确定医学成像特征在人类恶性肿瘤中的应用规则。使用 1000 例回顾性非小细胞肺癌患者的 CT 图像揭示了复杂纹理特征值分布的模式。
本研究共整理和评估了 930 篇原始文章中影响人体 20 个部位的 5026 种恶性肿瘤影像学特征。提出了一个元特征构建,以方便研究任何高维复杂恶性肿瘤的成像特征的细节。构建了一个相关图谱,以阐明将医学成像特征应用于人类恶性肿瘤分析的一般规则。对该数据的评估揭示了在整个人类恶性肿瘤中最常报道的纹理特征的价值分布模式。此外,在不同类型的人类恶性肿瘤中,基因突变特征 1B 的显著表达与运行长度成像特征的存在高度一致。
本研究结果可能有助于在广泛的人类恶性肿瘤的所有肿瘤学任务中更可信地选择影像学特征,并有助于减少未来医学影像学研究中的偏差和冗余。计算机辅助诊断(CAD),计算机应用一般(信息学),循证医学,信息学,研究设计,统计学,技术评估。在 CC BY 4.0 许可下发布。